(Q74404243)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12095562%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

Supraglottic carcinoma: patterns of failure and salvage treatment after curatively intended radiotherapy in 410 consecutive patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12095562%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12095562%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

Lars Vendelbo Johansen

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12095562%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Jens Overgaard

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12095562%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

language of work or name

English

0 references

publication date

1 July 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12095562%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Radiation Oncology Biology Physics

10 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12095562%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

53

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12095562%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12095562%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

948-958

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12095562%20AND%20SRC:MED&resulttype=core&format=json

Variation in survival of patients with head and neck cancer in Europe by the site of origin of the tumours. EUROCARE Working Group.

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902840-7

7 January 2021

Radiotherapy for squamous cell carcinoma of the supraglottic larynx: an alternative to surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902840-7

7 January 2021

Conservative management of T1-T2N0 supraglottic cancer: a retrospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902840-7

7 January 2021

331 cases of clinically node-negative supraglottic carcinoma of the larynx: a study of a modest size fixed field radiotherapy approach

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902840-7

7 January 2021

Initial treatment of the early stages (I, II) of supraglottic squamous cell carcinoma: partial laryngectomy versus radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902840-7

7 January 2021

Recurrence after different primary treatment for cancer of the supraglottic larynx

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902840-7

7 January 2021

Patterns of nodal metastasis and surgical management of the neck in supraglottic laryngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902840-7

7 January 2021

Management of carcinoma of the supraglottic larynx: evolution, current concepts, and future trends

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902840-7

7 January 2021

Prognostic determinants in supraglottic carcinoma: univariate and Cox regression analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902840-7

7 January 2021

Prognostic factors in supraglottic laryngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902840-7

7 January 2021

Transoral carbon dioxide laser resection of supraglottic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902840-7

7 January 2021

Endoscopic laser resection of supraglottic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902840-7

7 January 2021

Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902840-7

7 January 2021

Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902840-7

7 January 2021

Randomized trial of induction chemotherapy in larynx carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902840-7

7 January 2021

Primary radiotherapy of T1 squamous cell carcinoma of the larynx: analysis of 478 patients treated from 1963 to 1985

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902840-7

7 January 2021

Hypopharyngeal squamous cell carcinoma--treatment results in 138 consecutively admitted patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902840-7

7 January 2021

Squamous cell carcinoma of the oropharynx--an analysis of treatment results in 289 consecutive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902840-7

7 January 2021

Squamous cell carcinoma of the nasopharynx--an analysis of treatment results in 149 consecutive patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902840-7

7 January 2021

Glottic carcinoma--patterns of failure and salvage treatment after curative radiotherapy in 861 consecutive patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902840-7

7 January 2021

Misonidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of larynx and pharynx: report from the DAHANCA 2 study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902840-7

7 January 2021

A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902840-7

7 January 2021

Bleomycin, methotrexate and vincristine before irradiation of stage III and IV laryngeal and pharyngeal squamous cell carcinoma. A study initiated by the Danish Society of Head and Neck Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902840-7

7 January 2021

Pharyngo-cutaneous fistulae after laryngectomy. Influence of previous radiotherapy and prophylactic metronidazole

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902840-7

7 January 2021

Cancers of the upper aerodigestive tract in Ontario, Canada, and the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902840-7

7 January 2021

Why has induction chemotherapy for advanced head and neck cancer become a United States community standard of practice?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902840-7

7 January 2021

Treatment of the contralateral negative neck in supraglottic cancer patients with unilateral node metastases (N1-3)

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902840-7

7 January 2021

Controversies in the treatment of N(0) neck in laryngeal cancer: neck dissection, no surgery or sentinel lymph node biopsy?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902840-7

7 January 2021

Salvage surgery following radiation failure in squamous cell carcinoma of the supraglottic larynx

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902840-7

7 January 2021

The incidence and etiology of postlaryngectomy pharyngocutaneous fistulae

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902840-7

7 January 2021

A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902840-7

7 January 2021

Second neoplasm in patients with head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902840-7

7 January 2021

Second malignant neoplasia in patients with T1 glottic cancer treated with radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902840-7

7 January 2021

Multiple primary malignant tumours in patients with head and neck cancer: the implications for follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902840-7

7 January 2021

Second primary tumors in laryngeal cancer: results of long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902840-7

7 January 2021

Second primary neoplasms in patients with laryngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902840-7

7 January 2021

10.1016/S0360-3016(02)02840-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12095562%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference